10-Q: Bioethics, Ltd. Reports First Quarter 2024 Results with Continued Losses and No Revenue

Bioethics, Ltd. reported a net loss of $39,653 for the first quarter of 2024, with no revenue and ongoing concerns about its ability to continue as a going concern.

Summary

• Bioethics, Ltd. reported its financial results for the first quarter of 2024, ending March 31, 2024.
• The company did not generate any revenue during the quarter, consistent with the same period in the previous year.
• The company incurred a net loss of $39,653 for the quarter, which is higher than the $23,636 loss reported for the same period in 2023.
• Operating expenses increased to $27,221, up from $12,027 in the first quarter of 2023, primarily due to legal and accounting fees.
• The company's total liabilities were $816,011, while total assets were only $93, resulting in a significant working capital deficit of $815,918.
• The company's accumulated deficit since inception has reached $1,317,532.
• The company's cash and cash equivalents decreased from $138 at the end of 2023 to $93 at the end of the first quarter of 2024.
• The company is dependent on external funding sources such as loans, sales of securities, or contributions from stockholders to cover operating costs.
• Management has expressed concerns about the company's ability to continue as a going concern due to ongoing losses and lack of operations.

Sentiment

Score: 2

Explanation: The document paints a very negative picture due to the lack of revenue, increasing losses, significant working capital deficit, and a going concern warning. The company's reliance on external funding and ineffective internal controls further contribute to the low sentiment.

Negatives

• The company has no revenue.
• The company's net loss increased compared to the same period last year.
• The company has a significant working capital deficit.
• The company has a large accumulated deficit.
• The company's cash reserves are very low.
• The company is dependent on external funding.
• The company has a going concern warning.

Risks

• The company's ability to continue as a going concern is in doubt due to ongoing losses and lack of operations.
• The company is dependent on external funding, and there is no assurance that it will be able to obtain the necessary capital.
• The company has a significant working capital deficit and a large accumulated deficit.
• The company's internal controls over financial reporting are not effective.
• The company has not entered into any agreements for additional debt or equity financing.
• The company has multiple promissory notes in default.

Future Outlook

The company is seeking business opportunities for acquisition or participation and may need to raise additional funds through loans, sales of stock, or a business combination. There is no assurance that the company will be successful in raising additional capital or achieving profitable operations.

Management Comments

• Management believes that all necessary adjustments have been made to present fairly the financial position, results of operations, and cash flows for the three months ended March 31, 2024 and 2023.
• Management is proposing to raise any necessary additional funds not provided by operations through loans, additional sales of its common stock, or through a possible business combination.
• Management has concluded that the company's disclosure controls and procedures were not effective as of March 31, 2024.
• Management has concluded that the company's internal control over financial reporting was not effective as of September 30, 2023.

Industry Context

Bioethics, Ltd. is a shell company with no active business operations, making it difficult to compare to industry peers. The company's financial situation is not typical of operating companies, as it is primarily focused on finding a business opportunity for acquisition or participation.

Comparison to Industry Standards

• As a shell company with no active operations, Bioethics, Ltd. does not have comparable metrics to typical operating companies.
• The company's financial results are not comparable to companies with ongoing revenue generation and operational activities.
• The company's significant working capital deficit and accumulated losses are not typical of established businesses.
• The company's reliance on external funding and lack of revenue generation are not standard for most companies.

Related Party Transactions

• The company has related party transactions including rent expense for the use of the President's personal residence as the company's office and mailing address.
• The company has promissory notes with a newly-affiliated party and its President.
• The company received additional loans from related parties during the quarter.

Stakeholder Impact

• Shareholders face significant risk due to the company's financial instability and going concern warning.
• Employees are not directly impacted as the company has no ongoing operations.
• Creditors face risk due to the company's inability to repay its debts.
• Potential future stakeholders face risk due to the company's financial instability and lack of operations.

Next Steps

• The company will continue to seek business opportunities for acquisition or participation.
• The company will attempt to raise additional capital through loans, sales of stock, or a business combination.
• The company will need to address its ineffective internal controls over financial reporting.

Key Dates

Keywords

financial results, net loss, going concern, working capital deficit, promissory notes, related party transactions, shell company, operating expenses, accumulated deficit, internal controls